Zhancheng Qiu

机构：Sichuan University, West China Hospital of Sichuan University · ORCID：0009-0004-1749-3558

发表论文 21 篇 · 总被引 133 次 · h-index 7

代表论文

• Tumor burden score-AFP-albumin-bilirubin grade score predicts the survival of patients with hepatocellular carcinoma after liver resection (2023 · Langenbeck s Archives of Surgery · 被引 18)
• The application and prospection of augmented reality in hepato-pancreato-biliary surgery (2023 · BioScience Trends · 被引 17)
• PIVKA‐II combined with tumor burden score to predict long‐term outcomes of AFP ‐negative hepatocellular carcinoma patients after liver resection (2023 · Cancer Medicine · 被引 16)
• Establishing and Externally Validating a Hemoglobin, Albumin, Lymphocyte, and Platelet (HALP) Score-Based Nomogram for Predicting Early Recurrence in BCLC Stage 0/A Hepatocellular Carcinoma Patients After Radical Liver Resection: A Multi-Center Study (2024 · Journal of Hepatocellular Carcinoma · 被引 15)
• TIDE: adjuvant tislelizumab plus donafenib combined with transarterial chemoembolization for high-risk hepatocellular carcinoma after surgery: protocol for a prospective, single-arm, phase II trial (2023 · Frontiers in Oncology · 被引 13)
• Comparison of textbook outcomes between laparoscopic and open liver resection for patients with hepatocellular carcinoma: a multicenter study (2025 · Surgical Endoscopy · 被引 12)